Browsing by Author Pfizer Inc.
Showing results 14 to 16 of 16 < previous
|1-Jan-2014||Risk of tuberculosis with anti-tumor necrosis factor-α therapy: Substantially higher number of patients at risk in Asia||Sandra V. Navarra; Boxiong Tang; Liangjing Lu; Hsiao Yi Lin; Chi Chiu Mok; Paijit Asavatanabodee; Parawee Suwannalai; Heselynn Hussein; Mahboob U. Rahman; University of Santo Tomas, Manila; Pfizer Inc.; Renji Hospital; National Yang-Ming University Taiwan; Tuen Mun Hospital; Phramongkutklao College of Medicine; Mahidol University; Hospital Putrajaya; University of Pennsylvania|
|1-Jan-2020||Staphylococcus aureus capsular polysaccharides: A structural and synthetic perspective||Satsawat Visansirikul; Stephen A. Kolodziej; Alexei V. Demchenko; University of Missouri-St. Louis; Mahidol University; Pfizer Inc.|
|1-Dec-2012||The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics||J. G Coen van Hasselt; Marilee A. Andrew; Mary F. Hebert; Joel Tarning; Paolo Vicini; Donald R. Mattison; The Netherlands Cancer Institute; Amgen - Seattle Office; University of Washington, Seattle; Mahidol University; Pfizer Inc.; National Institute of Child Health and Human Development; Risk Sciences International, Ottawa|